Dr. Michael A Hoyt, PhD

Claim this profile
Studies Testicular Cancer
1 reported clinical trial
2 drugs studied

Area of expertise

1Testicular Cancer
Michael A Hoyt, PhD has run 1 trial for Testicular Cancer. Some of their research focus areas include:
Stage IV
Stage II
Stage III

Clinical Trials Michael A Hoyt, PhD is currently running

More about Michael A Hoyt, PhD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Michael A Hoyt, PhD has experience with
  • Goal-Focused Emotion-Regulation Therapy (GET)
  • Individual Supportive Listening
Breakdown of trials Michael A Hoyt, PhD has run

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael A Hoyt, PhD specialize in?
Michael A Hoyt, PhD focuses on Testicular Cancer and other conditions. In particular, much of their work with Testicular Cancer has involved Stage IV patients, or patients who are Stage II.
Is Michael A Hoyt, PhD currently recruiting for clinical trials?
Yes, Michael A Hoyt, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Michael A Hoyt, PhD has studied deeply?
Yes, Michael A Hoyt, PhD has studied treatments such as Goal-Focused Emotion-Regulation Therapy (GET), Individual Supportive Listening.
What is the best way to schedule an appointment with Michael A Hoyt, PhD?
Apply for one of the trials that Michael A Hoyt, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.